Veeva Systems (NYSE:VEEV) Given New $275.00 Price Target at Oppenheimer

Veeva Systems (NYSE:VEEV) had its price target lowered by Oppenheimer from $325.00 to $275.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the technology company’s stock.

A number of other analysts have also weighed in on the company. Wall Street Zen lowered Veeva Systems from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Weiss Ratings downgraded shares of Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. UBS Group decreased their price objective on shares of Veeva Systems from $280.00 to $200.00 and set a “neutral” rating for the company in a report on Friday, February 20th. BMO Capital Markets initiated coverage on shares of Veeva Systems in a research note on Thursday, November 13th. They issued a “market perform” rating and a $300.00 target price on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of Veeva Systems in a research report on Tuesday, January 13th. They set a “sell” rating and a $215.00 target price on the stock. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $300.50.

Veeva Systems Price Performance

Shares of NYSE:VEEV opened at $175.60 on Tuesday. The firm has a market capitalization of $28.87 billion, a PE ratio of 34.16, a price-to-earnings-growth ratio of 1.19 and a beta of 1.08. The business has a 50 day simple moving average of $209.17 and a two-hundred day simple moving average of $252.18. Veeva Systems has a 1 year low of $168.13 and a 1 year high of $310.50.

Veeva Systems declared that its board has approved a stock buyback program on Monday, January 5th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the technology company to repurchase up to 5.5% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of Veeva Systems stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total value of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at $5,370,101.72. The trade was a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Veeva Systems

Hedge funds have recently modified their holdings of the stock. Linden Thomas Advisory Services LLC increased its stake in Veeva Systems by 0.3% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 12,444 shares of the technology company’s stock valued at $3,707,000 after purchasing an additional 35 shares in the last quarter. Sigma Planning Corp grew its holdings in shares of Veeva Systems by 1.2% during the second quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after buying an additional 39 shares during the last quarter. Personal CFO Solutions LLC grew its holdings in shares of Veeva Systems by 3.5% during the third quarter. Personal CFO Solutions LLC now owns 1,163 shares of the technology company’s stock valued at $346,000 after buying an additional 39 shares during the last quarter. AFT Forsyth & Company Inc. increased its position in shares of Veeva Systems by 4.2% in the 3rd quarter. AFT Forsyth & Company Inc. now owns 984 shares of the technology company’s stock valued at $293,000 after acquiring an additional 40 shares during the period. Finally, Williams Jones Wealth Management LLC. raised its stake in Veeva Systems by 0.4% in the 3rd quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock worth $2,806,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Bullish investor write‑up arguing for a long-term hold, supporting demand from buy‑and‑hold investors. 1 Reason I’d Buy Veeva Systems Stock and Never Sell
• Neutral Sentiment: Market note: a brief price uptick was reported yesterday, reflecting short‑term buying momentum rather than a clear fundamental catalyst. Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
• Neutral Sentiment: Oppenheimer lowered its price target from $325 to $275 but kept an “outperform” rating, leaving a sizable implied upside while signaling reduced near‑term expectations. Oppenheimer lowers price target
• Negative Sentiment: UBS trimmed its price target to $200, a meaningful cut that reduces analyst support and may pressure sentiment. UBS Group Cuts Veeva Systems Price Target to $200
• Negative Sentiment: JPMorgan lowered its target to $296, another analyst downgrade to consider; multiple PT cuts compress consensus upside. JPMorgan Cuts Veeva Systems Price Target to $296
• Negative Sentiment: Artisan Mid Cap Fund disclosed selling its Veeva stake in Q4 2025, indicating institutional trimming that can add selling pressure. Here’s Why Artisan Mid Cap Fund Sold Its Position in Veeva Systems
• Negative Sentiment: Several fund letters note Veeva traded lower despite solid results — suggests some investors are taking profits or rotating out, which can amplify downside near term. Veeva Systems Traded Lower Despite Impressive Results

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.